SCHEMBL23084956

SCHEMBL23084956

C#CCOc1ccc(C(C)(c2ccc(OCC(=C)C)cc2)c2ccc(-c3ccccc3)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 9/20 0.45
▸ MAOA P21397 7/20 0.45
▸ MAPT P10636 4/20 0.43
▸ LMNA P02545 4/20 0.43
▸ NPC1 O15118 3/20 0.43
▸ CASP3 P42574 1/20 0.43
▸ SENP8 Q96LD8 1/20 0.43
▸ SENP7 Q9BQF6 1/20 0.43
▸ SENP6 Q9GZR1 1/20 0.43
▸ GPR174 Q9BXC1 1/20 0.42
▸ RAB9A P51151 2/20 0.41
▸ KDM1A O60341 1/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ GSTP1 P09211 1/20 0.39
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9546410 0.83 GPR174 (0.54) MAPTLMNANPC1CASP3SENP8
SCHEMBL23813386 0.81 MAOB (0.48) MAOBMAOASMN1; SMN2GSTP1MEN1
SCHEMBL2429681 0.80 GPR174 (0.59) MAPTLMNANPC1CASP3SENP8
SCHEMBL4278557 0.78 CA12 (0.49) MAOBMAOASMN1; SMN2GSTP1ALDH1A1
SCHEMBL536433 0.77 MAOB (0.68) MAOBMAOAKDM1AGSTP1
SCHEMBL23085090 0.75 MAOB (0.39) MAOBMAOA
SCHEMBL14222920 0.74 ESR1 (0.47) MAOBMAOALMNAGSTP1MEN1
SCHEMBL15803992 0.74 CA12 (0.45) MAOBMAOAMAPTSMN1; SMN2GSTP1
SCHEMBL5931918 0.73 GPR174 (0.53) MAPTLMNANPC1CASP3SENP8
SCHEMBL8507007 0.72 SMN1; SMN2 (0.57) MAOBMAOALMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210070727-A1 COMPOUND, RESIN, COMPOSITION AND PATTERN FORMATION METHOD MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-03-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210070727-A1 COMPOUND, RESIN, COMPOSITION AND PATTERN FORMATION METHOD RDX, RTN4, CROCC MAOB 3491/4885MAOA 3602/4885MAPT 1674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback